multiplex protein diagnostics
Bio-Techne, Nonagen Bioscience Ink Agreement to Manufacture Multiplex Bladder Cancer Panel
Bio-Techne will manufacture Nonagen's Oncuria, a protein-based urine test for the early detection, therapy choice, and disease monitoring of bladder cancer.
Pancreatic Cancer Application Provides First Toehold for Biological Dynamics in Clinical Testing
Premium
The company is validating early promising data for an exosomal-protein based signature to identify asymptomatic individuals with early pancreatic cancer.
NanoString Technologies, OHSU Partner on Breast Cancer Spatial Protein Profiling Assay Development
A new GeoMx Digital Spatial Profiler assay will have up to 30 protein targets and will be validated for potential use as a laboratory-developed test.
Inflammatory Cytokine Biomarkers Predict COVID-19 Survival, Could Yield Dx, Rx Targets
Mount Sinai researchers investigated four cytokine proteins and found that two of them were elevated in the serum samples of SARS-CoV-2 patients who fared the worst.
Judge Allows Whistleblower Suit Against Myriad Genetics to Proceed
In January a federal court unsealed a False Claims Act suit from an industry insider that alleges a Myriad subsidiary engaged in a fraudulent kickback scheme.